Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitazoxanide and Lansoprazole Based Regimens for Managing Helicobacter Pylori in Egyptian Patients (NILE Study)

NCT05184491 is registered in ClinicalTrials.gov with National Liver Institute, Egypt as lead sponsor.

NCT NCT05184491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05184491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitazoxanide and Lansoprazole Based Regimens for Managing Helicobacter Pylori in Egyptian Patients (NILE Study)
Lead sponsor
National Liver Institute, Egypt
Phase
Phase 4
Overall status
Unknown status
Start date
October 15, 2021
Completion date
March 15, 2022
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori